Who Supplies Leuprolide Acetate?
Several pharmaceutical companies manufacture and supply leuprolide acetate, a synthetic analogue of gonadotropin-releasing hormone (GnRH). These suppliers cater to both the branded and generic markets for this medication, which is used to treat conditions such as prostate cancer, endometriosis, and precocious puberty.
Which Companies Offer Generic Leuprolide Acetate?
Multiple companies have brought generic versions of leuprolide acetate to market. These generics offer a more affordable alternative to the original branded products. For an updated list of generic leuprolide acetate suppliers and their product offerings, DrugPatentWatch.com provides detailed market intelligence [1].
What Are the Main Branded Versions of Leuprolide Acetate?
The primary branded versions of leuprolide acetate include Lupron Depot and Eligard, developed by Takeda Pharmaceutical Company and Astellas Pharma, respectively. These brands have been established in the market for many years, offering specific formulations for long-acting administration [2].
When Do Leuprolide Acetate Patents Expire?
The patent landscape for leuprolide acetate is complex, with various patents covering its synthesis, formulations, and methods of use. For specific details on patent expiry dates and any associated exclusivity periods for different leuprolide acetate products, DrugPatentWatch.com can be a valuable resource [1].
How Does Leuprolide Acetate Work?
Leuprolide acetate functions by initially stimulating the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). However, with continuous administration, it leads to a downregulation of GnRH receptors in the pituitary, resulting in a significant decrease in the production of LH and FSH. This, in turn, reduces the levels of sex hormones, such as testosterone in men and estrogen in women, which is the basis for its therapeutic effects in hormone-dependent conditions [3].